Search
| Leader | 00000nz a2200037n 45 0 | ||
|---|---|---|---|
| 001 | WKP|Q44062339 (VIAF cluster) (Authority/Source Record) | ||
| 003 | WKP | ||
| 005 | 20241221010839.0 | ||
| 008 | 241221nneanz||abbn n and d | ||
| 035 | ‡a (WKP)Q44062339 | ||
| 024 | ‡a 0000-0002-4730-0938 ‡2 orcid | ||
| 024 | ‡a 7004969192 ‡2 scopus | ||
| 035 | ‡a (OCoLC)Q44062339 | ||
| 043 | ‡c ES | ||
| 046 | ‡f 19560000 | ||
| 100 | 0 | ‡a Maria Cinta Cid i Xutglà ‡c ikertzailea ‡9 eu | |
| 375 | ‡a 2 ‡2 iso5218 | ||
| 400 | 0 | ‡a Maria Cinta Cid i Xutglà ‡c investigadora ‡9 ca | |
| 400 | 0 | ‡a Maria Cinta Cid i Xutglà ‡c investigadora ‡9 es | |
| 400 | 0 | ‡a Maria Cinta Cid i Xutglà ‡c chercheuse ‡9 fr | |
| 400 | 0 | ‡a Maria Cinta Cid Xutglà ‡c researcher ‡9 en | |
| 400 | 0 | ‡a Maria C. Cid ‡c wetenschapper ‡9 nl | |
| 400 | 0 | ‡a Maria Cinta Cid i Xutglà ‡c investigadora ‡9 pt | |
| 400 | 0 | ‡a Maria C. Cid ‡c investigadora ‡9 ast | |
| 400 | 0 | ‡a Maria Cinta Cid i Xutglà ‡c ricercatrice ‡9 it | |
| 670 | ‡a Author's 2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative | ||
| 670 | ‡a Author's A candidate gene approach identifies an IL33 genetic variant as a novel genetic risk factor for GCA | ||
| 670 | ‡a Author's A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility | ||
| 670 | ‡a Author's A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis | ||
| 670 | ‡a Author's Antiangiogenic effects of anti-tumor necrosis factor alpha therapy with infliximab in psoriatic arthritis | ||
| 670 | ‡a Author's Bone marrow angiogenesis and angiogenic factors in multiple myeloma treated with novel agents | ||
| 670 | ‡a Author's Clinical and genetic characterization of the autoinflammatory diseases diagnosed in an adult reference center | ||
| 670 | ‡a Author's Description and Validation of Histological Patterns and Proposal of a Dynamic Model of Inflammatory Infiltration in Giant-cell Arteritis | ||
| 670 | ‡a Author's Dual function of focal adhesion kinase in regulating integrin-induced MMP-2 and MMP-9 release by human T lymphoid cells | ||
| 670 | ‡a Author's Genetics of carney triad: recurrent losses at chromosome 1 but lack of germline mutations in genes associated with paragangliomas and gastrointestinal stromal tumors | ||
| 670 | ‡a Author's Imaging in systemic vasculitis | ||
| 670 | ‡a Author's Life-Threatening Cryoglobulinemic Patients With Hepatitis C: Clinical Description and Outcome of 279 Patients | ||
| 670 | ‡a Author's Patient-reported outcomes in polymyalgia rheumatica | ||
| 670 | ‡a Author's Response to thalidomide in multiple myeloma: impact of angiogenic factors | ||
| 670 | ‡a Author's Selective up-regulation of the soluble pattern-recognition receptor pentraxin 3 and of vascular endothelial growth factor in giant cell arteritis: Relevance for recent optic nerve ischemia | ||
| 670 | ‡a Author's SOX11 promotes tumor protective microenvironment interactions through CXCR4 and FAK regulation in mantle cell lymphoma. | ||
| 670 | ‡a Author's Stimulatory autoantibodies to the PDGF receptor in scleroderma. | ||
| 670 | ‡a Author's The cryoglobulinaemias | ||
| 670 | ‡a Author's The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitis. | ||
| 670 | ‡a wikidata authority control ‡u https://viaf.org/processed/BNE|XX5229006 | ||
| 670 | ‡a wikidata site links ‡u https://ca.wikipedia.org/wiki/Maria_Cinta_Cid_i_Xutglà | ||
| 909 | ‡a (orcid) 0000000247300938 ‡9 1 | ||
| 909 | ‡a (scopus) 7004969192 ‡9 1 | ||
| 912 | ‡a largescalegeneticanalysisrevealsastrongcontributionofthehlaclass2regiontogiantcellarteritissusceptibility ‡A A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility ‡9 1 | ||
| 919 | ‡a impactof18ffdgpetonthemanagementofpatientswithsuspectedlargevesselvasculitis ‡A The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitis. ‡9 1 | ||
| 919 | ‡a cryoglobulinaemias ‡A The cryoglobulinaemias ‡9 1 | ||
| 919 | ‡a stimulatoryautoantibodiestothepdgfreceptorinscleroderma ‡A Stimulatory autoantibodies to the PDGF receptor in scleroderma. ‡9 1 | ||
| 919 | ‡a sox11promotestumorprotectivemicroenvironmentinteractionsthroughcxcr4andfakregulationinmantlecelllymphoma ‡A SOX11 promotes tumor protective microenvironment interactions through CXCR4 and FAK regulation in mantle cell lymphoma. ‡9 1 | ||
| 919 | ‡a selectiveupregulationofthesolublepatternrecognitionreceptorpentraxin3andofvascularendothelialgrowthfactoringiantcellarteritisrelevanceforrecentopticnerveischemia ‡A Selective up-regulation of the soluble pattern-recognition receptor pentraxin 3 and of vascular endothelial growth factor in giant cell arteritis: Relevance for recent optic nerve ischemia ‡9 1 | ||
| 919 | ‡a responsetothalidomideinmultiplemyelomaimpactofangiogenicfactors ‡A Response to thalidomide in multiple myeloma: impact of angiogenic factors ‡9 1 | ||
| 919 | ‡a patientreportedoutcomesinpolymyalgiarheumatica ‡A Patient-reported outcomes in polymyalgia rheumatica ‡9 1 | ||
| 919 | ‡a lifethreateningcryoglobulinemicpatientswithhepatitis100clinicaldescriptionandoutcomeof279patients ‡A Life-Threatening Cryoglobulinemic Patients With Hepatitis C: Clinical Description and Outcome of 279 Patients ‡9 1 | ||
| 919 | ‡a imaginginsystemicvasculitis ‡A Imaging in systemic vasculitis ‡9 1 | ||
| 919 | ‡a geneticsofcarneytriadrecurrentlossesatchromosome1butlackofgermlinemutationsingenesassociatedwithparagangliomasandgastrointestinalstromaltumors ‡A Genetics of carney triad: recurrent losses at chromosome 1 but lack of germline mutations in genes associated with paragangliomas and gastrointestinal stromal tumors ‡9 1 | ||
| 919 | ‡a dualfunctionoffocaladhesionkinaseinregulatingintegrininducedmmp2andmmp9releasebyhumantlymphoidcells ‡A Dual function of focal adhesion kinase in regulating integrin-induced MMP-2 and MMP-9 release by human T lymphoid cells ‡9 1 | ||
| 919 | ‡a descriptionandvalidationofhistologicalpatternsandproposalofadynamicmodelofinflammatoryinfiltrationingiantcellarteritis ‡A Description and Validation of Histological Patterns and Proposal of a Dynamic Model of Inflammatory Infiltration in Giant-cell Arteritis ‡9 1 | ||
| 919 | ‡a clinicalandgeneticcharacterizationoftheautoinflammatorydiseasesdiagnosedinanadultreferencecenter ‡A Clinical and genetic characterization of the autoinflammatory diseases diagnosed in an adult reference center ‡9 1 | ||
| 919 | ‡a bonemarrowangiogenesisandangiogenicfactorsinmultiplemyelomatreatedwithnovelagents ‡A Bone marrow angiogenesis and angiogenic factors in multiple myeloma treated with novel agents ‡9 1 | ||
| 919 | ‡a antiangiogeniceffectsofantitumornecrosisfactoralphatherapywithinfliximabinpsoriaticarthritis ‡A Antiangiogenic effects of anti-tumor necrosis factor alpha therapy with infliximab in psoriatic arthritis ‡9 1 | ||
| 919 | ‡a multicenterrandomizeddoubleblindplacebocontrolledtrialofadjuvantmethotrexatetreatmentforgiantcellarteritis ‡A A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis ‡9 1 | ||
| 919 | ‡a candidategeneapproachidentifiesanil33geneticvariantasanovelgeneticriskfactorforgca ‡A A candidate gene approach identifies an IL33 genetic variant as a novel genetic risk factor for GCA ‡9 1 | ||
| 919 | ‡a 2012provisionalclassificationcriteriaforpolymyalgiarheumaticaaeuropeanleagueagainstrheumatismamericancollegeofrheumatologycollaborativeinitiative ‡A 2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative ‡9 1 | ||
| 946 | ‡a a ‡9 1 | ||
| 947 | ‡a ES ‡9 1 | ||
| 996 | ‡2 ISNI|0000000382595070 | ||
| 996 | ‡2 LC|no2019061262 | ||
| 996 | ‡2 SUDOC|061633623 | ||
| 996 | ‡2 RERO|A009393400 | ||
| 996 | ‡2 ISNI|000000009358800X | ||
| 996 | ‡2 DNB|1203102399 | ||
| 996 | ‡2 NKC|ola20231201064 | ||
| 996 | ‡2 BIBSYS|10012459 | ||
| 996 | ‡2 PLWABN|9813311268205606 | ||
| 996 | ‡2 ISNI|0000000434315772 | ||
| 996 | ‡2 BNE|XX880515 | ||
| 996 | ‡2 NKC|jo2018981538 | ||
| 996 | ‡2 LC|n 2013188233 | ||
| 996 | ‡2 RERO|A025848183 | ||
| 996 | ‡2 LC|n 97111207 | ||
| 996 | ‡2 LC|no2021027770 | ||
| 996 | ‡2 SUDOC|152476679 | ||
| 996 | ‡2 BNE|XX848209 | ||
| 996 | ‡2 SUDOC|087692694 | ||
| 996 | ‡2 CAOONL|ncf11051940 | ||
| 996 | ‡2 PTBNP|787016 | ||
| 996 | ‡2 BNF|14598383 | ||
| 996 | ‡2 ISNI|0000000061073482 | ||
| 996 | ‡2 LC|no2011072408 | ||
| 996 | ‡2 ISNI|000000050048724X | ||
| 996 | ‡2 BIBSYS|4096832 | ||
| 996 | ‡2 BNE|XX1054546 | ||
| 996 | ‡2 BNE|XX938057 | ||
| 996 | ‡2 BNE|XX1107073 | ||
| 996 | ‡2 NII|DA1508546X | ||
| 996 | ‡2 BNC|981058611995206706 | ||
| 996 | ‡2 ISNI|0000000107777013 | ||
| 996 | ‡2 BNF|14621854 | ||
| 996 | ‡2 BNF|13740267 | ||
| 996 | ‡2 BNC|981058520134006706 | ||
| 996 | ‡2 DNB|1159199930 | ||
| 996 | ‡2 BNE|XX1161425 | ||
| 996 | ‡2 BLBNB|001482097 | ||
| 996 | ‡2 SUDOC|15061702X | ||
| 996 | ‡2 ISNI|0000000497778619 | ||
| 996 | ‡2 RERO|A000074088 | ||
| 996 | ‡2 BNE|XX5229006 | ||
| 996 | ‡2 BNCHL|10000000000000000222194 | ||
| 996 | ‡2 DNB|143626884 | ||
| 996 | ‡2 ISNI|0000000001312269 | ||
| 996 | ‡2 LC|nb2003078236 | ||
| 996 | ‡2 ISNI|0000000105430358 | ||
| 996 | ‡2 BNE|XX1605805 | ||
| 996 | ‡2 SUDOC|032321503 | ||
| 996 | ‡2 ISNI|0000000466508202 | ||
| 996 | ‡2 LC|nr 95045540 | ||
| 996 | ‡2 SUDOC|188225609 | ||
| 996 | ‡2 NII|DA19790361 | ||
| 996 | ‡2 DNB|1057488143 | ||
| 996 | ‡2 BNE|XX1587737 | ||
| 996 | ‡2 ISNI|0000000119595591 | ||
| 996 | ‡2 SUDOC|257589406 | ||
| 996 | ‡2 J9U|987007354264605171 | ||
| 996 | ‡2 ISNI|0000000500281495 | ||
| 996 | ‡2 ISNI|0000000069116328 | ||
| 996 | ‡2 SUDOC|084274751 | ||
| 996 | ‡2 BNE|XX4899530 | ||
| 996 | ‡2 BNE|XX839066 | ||
| 996 | ‡2 BNF|16763916 | ||
| 996 | ‡2 BNC|981058516246906706 | ||
| 996 | ‡2 BNE|XX5506931 | ||
| 996 | ‡2 NUKAT|n 2015139521 | ||
| 996 | ‡2 ISNI|0000000070333741 | ||
| 996 | ‡2 BIBSYS|10012311 | ||
| 996 | ‡2 LC|no2007149148 | ||
| 996 | ‡2 ISNI|0000000434909335 | ||
| 996 | ‡2 SUDOC|096322896 | ||
| 996 | ‡2 ISNI|0000000447238577 | ||
| 996 | ‡2 BNC|981058611809006706 | ||
| 996 | ‡2 BNE|XX932410 | ||
| 996 | ‡2 LC|ns2016004499 | ||
| 996 | ‡2 LIH|LNB:C_f_7_q_;=B_x_ | ||
| 996 | ‡2 PTBNP|1669243 | ||
| 996 | ‡2 ISNI|0000000060207346 | ||
| 996 | ‡2 SUDOC|249801086 | ||
| 996 | ‡2 PTBNP|1876690 | ||
| 996 | ‡2 BNCHL|10000000000000000856408 | ||
| 996 | ‡2 ISNI|0000000365933277 | ||
| 996 | ‡2 DNB|1187969036 | ||
| 996 | ‡2 SUDOC|166613282 | ||
| 996 | ‡2 ISNI|0000000039103526 | ||
| 996 | ‡2 ISNI|0000000431109359 | ||
| 996 | ‡2 BNC|981058519258506706 | ||
| 996 | ‡2 ISNI|0000000060729961 | ||
| 996 | ‡2 LC|no2016161271 | ||
| 996 | ‡2 BNC|981058617779206706 | ||
| 996 | ‡2 BNCHL|10000000000000000262085 | ||
| 996 | ‡2 ISNI|0000000397695162 | ||
| 996 | ‡2 LC|nb2015003945 | ||
| 996 | ‡2 SUDOC|249725010 | ||
| 996 | ‡2 ISNI|0000000034818119 | ||
| 996 | ‡2 LC|no2019089567 | ||
| 996 | ‡2 BNCHL|10000000000000000069331 | ||
| 996 | ‡2 LC|no2019089671 | ||
| 997 | ‡a 1956 0 lived 0000 0 ‡9 1 | ||
| 998 | ‡a Cid Xutglà, M. Cinta ‡2 BNE|XX5229006 ‡3 suggested | ||
| 998 | ‡a Cid Xutglà, M. Cinta ‡2 BNC|981058510917906706 ‡3 suggested ‡3 standard number |
